Literature DB >> 23121021

Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features.

Fabrice Bonnet1, Fritz-Line Velayoudom Cephise, Alain Gautier, Séverine Dubois, Catherine Massart, Alioune Camara, Laurent Larifla, Beverley Balkau, Pierre-Henri Ducluzeau.   

Abstract

BACKGROUND: SHBG and liver enzymes levels are both associated with the risk of type 2 diabetes. However, the relationship between SHBG with liver enzymes and intrahepatic fat content remain poorly understood.
OBJECTIVE: To investigate whether SHBG is correlated with glucose and lipids levels and whether this association depends on fatty liver content, liver enzymes or sex hormone concentrations. DESIGN AND PATIENTS: We studied 233 dysmetabolic men with measures of plasma SHBG, total testosterone, 17β-oestradiol, glucose, adiponectin, liver enzymes and hepatokines. Intrahepatic liver fat and visceral fat contents were measured by magnetic resonance imaging in 108 of these individuals.
RESULTS: After adjustment for age, SHBG concentration was inversely correlated with fasting glucose (βstandardized  = -0·21, P = 0·0007), HbA1c (βstandardized  = -0·27, P < 0·0001), triglycerides (βstandardized  = -0·19, P = 0·003) and positively correlated with HDL-Cholesterol (βstandardized  = 0·14, P = 0·03). These correlations persisted after adjustment for either total testosterone or 17β-oestradiol levels. SHBG was not related to either fetuin A or FGF 21 concentrations. The inverse association of SHBG with HbA1c and glycaemia was not altered after adjusting for liver markers but was no longer significant after adjustment for hepatic fat content.
CONCLUSION: The significant association between SHBG and fasting glycaemia, HbA1c and lipid levels in dysmetabolic men was not related to either sex hormones or markers of liver function, but was dependent on intrahepatic fat. This suggests that intrahepatic fat, but not alterations in liver function markers, may be involved in the association between SHBG and glucose and lipid metabolism.
© 2012 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23121021     DOI: 10.1111/cen.12089

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.

Authors:  Johannes D Veldhuis; Olga P Bondar; Roy B Dyer; Sergey A Trushin; Eric W Klee; Ravinder J Singh; George G Klee
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.

Authors:  C Kim; S D Harlow; C A Karvonen-Gutierrez; J F Randolph; M Helmuth; S Kong; B Nan; R Carlos
Journal:  Diabet Med       Date:  2013-06-07       Impact factor: 4.359

3.  Endogenous sex steroid hormones and glucose in a South-Asian population without diabetes: the Metabolic Syndrome and Atherosclerosis in South-Asians Living in America pilot study.

Authors:  B L Needham; C Kim; B Mukherjee; P Bagchi; F Z Stanczyk; A M Kanaya
Journal:  Diabet Med       Date:  2014-12-11       Impact factor: 4.359

4.  Association between sex hormone binding globulin gene polymorphism and type 2 diabetes mellitus.

Authors:  Li Quan; Liang Wang; Jing Wang; Binya Yuwen; Jun Zhu
Journal:  Int J Clin Exp Pathol       Date:  2019-09-01

5.  Is serum sex hormone-binding globulin a dominant risk factor for metabolic syndrome?

Authors:  Yi-Hong Yang; Ming-Jia Zhao; Shan-Jie Zhou; Wen-Hong Lu; Xiao-Wei Liang; Cheng-Liang Xiong; Chang-Chun Wan; Xue-Jun Shang; Yi-Qun Gu
Journal:  Asian J Androl       Date:  2015 Nov-Dec       Impact factor: 3.285

6.  Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome.

Authors:  Hannah Steeb; Jordan M Ramsey; Paul C Guest; Pawel Stocki; Jason D Cooper; Hassan Rahmoune; Erin Ingudomnukul; Bonnie Auyeung; Liliana Ruta; Simon Baron-Cohen; Sabine Bahn
Journal:  Mol Autism       Date:  2014-01-27       Impact factor: 7.509

7.  Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients.

Authors:  Xiaomin Hua; Man Li; Fenghui Pan; Yunyun Xiao; Wenxia Cui; Yun Hu
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

Review 8.  Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.

Authors:  Hirokazu Takahashi; Kazuhiko Kotani; Kenichi Tanaka; Yuichiro Egucih; Keizo Anzai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

9.  Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men.

Authors:  Prabin Gyawali; Sean A Martin; Leonie K Heilbronn; Andrew D Vincent; Alicia J Jenkins; Andrzej S Januszewski; Anne W Taylor; Robert J T Adams; Peter D O'Loughlin; Gary A Wittert
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.